Reportable Segments (Tables)

9 Months Ended

Sep. 30, 2025

Reportable Segment Financial Information

The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations.

Reportable Segment Financial Information (in thousands):


	Three Months Ended September 30, 2025
	EMG		EIG		Corporate		Total Consolidated
Net Sales	$	646,309	$	1,246,332	$	—	$	1,892,641
Cost of sales (1)	460,061		746,444		—		1,206,505
Selling expense	22,373		147,451		—		169,824
Segment Operating Income	163,875		352,437		—		516,312
Corporate G&A	—		—		27,932		27,932
Operating Income	163,875		352,437		(27,932)		488,380
Interest expense	—		—		(22,514)		(22,514)
Other (expense) income, net (2)	—		—		(17,901)		(17,901)
Income before Income Taxes	$	163,875	$	352,437	$	(68,347)	$	447,965

Depreciation	14,964		19,409		1,407		35,780
Amortization	18,711		48,587		—		67,298
Total depreciation and amortization	$	33,675	$	67,996	$	1,407	$	103,078

Research, Development & Engineering costs (3)	$	19,995	$	74,686	$	—	$	94,681

Assets	$	4,837,524	$	10,717,580	$	627,153	$	16,182,257
Capital Expenditures (4)	$	7,929	$	12,984	$	—	$	20,913

(1)Includes $7.8 million of acquisition-related costs.

(2)Includes $12.0 million of acquisition-related costs.

(3)Included in cost of sales.

(4)Excludes $23.1 million of acquired capital expenditures in EIG.


	Three Months Ended September 30, 2024
	EMG		EIG		Corporate		Total Consolidated
Net Sales	$	573,976	$	1,134,588	$	—	$	1,708,564
Cost of sales	420,375		672,379		—		1,092,754
Selling expense	22,082		123,246		—		145,328
Segment Operating Income	131,519		338,963		—		470,482
Corporate G&A	—		—		24,631		24,631
Operating Income	131,519		338,963		(24,631)		445,851
Interest expense	—		—		(25,118)		(25,118)
Other (expense) income, net	—		—		(1,888)		(1,888)
Income before Income Taxes	$	131,519	$	338,963	$	(51,637)	$	418,845

Depreciation	$	12,120	$	17,123	$	1,303	$	30,546
Amortization	16,716		43,105		—		59,821
Total depreciation and amortization	$	28,836	$	60,228	$	1,303	$	90,367

Research, Development & Engineering costs (1)	$	17,692	$	76,623	$	—	$	94,315

Assets	$	4,850,224	$	9,384,031	$	533,384	$	14,767,639
Capital Expenditures	$	9,073	$	13,622	$	3,587	$	26,282

(1)Included in cost of sales.


	Nine Months Ended September 30, 2025
	EMG		EIG		Corporate		Total Consolidated
Net Sales	$	1,853,092	$	3,549,576	$	—	$	5,402,668
Cost of sales (1)	1,349,981		2,105,662		—		3,455,643
Selling expense	66,630		392,999		—		459,629
Segment Operating Income	436,481		1,050,915		—		1,487,396
Corporate G&A	—		—		82,561		82,561
Operating Income	436,481		1,050,915		(82,561)		1,404,835
Interest expense	—		—		(58,364)		(58,364)
Other (expense) income, net (2)	—		—		(22,115)		(22,115)
Income before Income Taxes	$	436,481	$	1,050,915	$	(163,040)	$	1,324,356

Depreciation	$	46,022	$	57,296	$	4,324	$	107,642
Amortization	72,166		137,338		—		209,504
Total depreciation and amortization	$	118,188	$	194,634	$	4,324	$	317,146

Research, Development & Engineering costs (3)	$	62,270	$	221,503	$	—	$	283,773


Capital Expenditures (4)	$	25,286	$	34,653	$	13,312	$	73,251

(1)Includes $7.8 million of acquisition-related costs.

(2)Includes $12.0 million of acquisition-related costs.

(3)Included in cost of sales.

(4)Excludes $33.9 million of acquired capital expenditures in EIG.


	Nine Months Ended September 30, 2024
	EMG		EIG		Corporate		Total Consolidated
Net Sales	$	1,734,598	$	3,444,980	$	—	$	5,179,578
Cost of sales (1)	1,322,180		2,025,680		—		3,347,860
Selling expense	67,106		377,540		—		444,646
Segment Operating Income	345,312		1,041,760		—		1,387,072
Corporate G&A	—		—		76,491		76,491
Operating Income	345,312		1,041,760		(76,491)		1,310,581
Interest expense	—		—		(90,962)		(90,962)
Other (expense) income, net	—		—		(2,435)		(2,435)
Income before Income Taxes	$	345,312	$	1,041,760	$	(169,888)	$	1,217,184

Depreciation	$	44,802	$	52,553	$	4,338	$	101,693
Amortization	55,925		129,431		—		185,356
Total depreciation and amortization	$	100,727	$	181,984	$	4,338	$	287,049

Research, Development & Engineering costs (2)	$	36,864	$	153,576	$	—	$	190,440


Capital Expenditures	$	27,845	$	36,765	$	10,740	$	75,350

(1)Includes $29.2 million in EMG for Paragon acquisition-related costs.

(2)Included in cost of sales.

AMETEK INC/ 10-Q